Breaking News
12 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
FDA's full approval of Veklury sets a precedent for EUA-to-approval transitions, with direct implications for manufacturers in accelerated regulatory frameworks.
Pharma Now Editorial Team

FDA issues EUA for Gohibic (vilobelimab) IV injection in hospitalized COVID-19 adults on mechanical ventilation, setting sterile injectable and labeling benchmarks.
Pharma Now Editorial Team

FDA's 2020 remdesivir EUA offers a durable framework reference for manufacturers structuring regulatory dossiers under emergency authorization pathways.
Pharma Now Editorial Team

FDA issued a March 2026 approval letter for MSP Vaccine Company's VAXELIS, the hexavalent pediatric combination vaccine licensed under STN 125563.
Pharma Now Editorial Team
